Tresiba

Novo and Sanofi make case for hypo-reducing insulins at EASD
Novo and Sanofi make case for hypo-reducing insulins at EASD
Pharmaforum
Novo Nordisk
Sanofi
EASD
diabetes
hypoglycemia
insulin
Lantus
Tresiba
Flag link:
5 Biggest Blockbuster Diabetes Drugs of the Future
5 Biggest Blockbuster Diabetes Drugs of the Future
Motley Fool
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Boehringer Ingelheim
Jardiance
Tresiba
NovoRapid
Flag link:
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
FDA approves label update to Novo Nordisk’s Tresiba diabetes drug
Drug Delivery Business News
FDA
Novo Nordisk
diabetes
Tresiba
labeling
insulin degludec
Flag link:
Sanofi touts head-to-head comparison of long-acting insulin products
Sanofi touts head-to-head comparison of long-acting insulin products
Drug Delivery Business News
Sanofi
insulin
diabetes
Toujeo
long-acting insulin
Novo Nordisk
Tresiba
Flag link:
The best drug is not always a guarantee for the best financial results
The best drug is not always a guarantee for the best financial results
GoInPharma
Novo Nordisk
Tresiba
diabetes
insulin
Flag link:
Novo Nordisk touts late-stage trial data for Tresiba insulin injection
Novo Nordisk touts late-stage trial data for Tresiba insulin injection
Drug Delivery Business News
Novo Nordisk
Tresiba
insulin
clinical trials
diabetes
Flag link:
Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label
Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label
Fierce Pharma
Novo Nordisk
Lantus
Tresiba
diabetes
Europe
EMA
insulin
Flag link:
ADA preview: 5 things to watch in diabetes
ADA preview: 5 things to watch in diabetes
BioPharma Dive
ADA
diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
Lantus
Tresiba
JNJ
Novo Nordisk
PCSK9 inhibitors
Amgen Regeneron
Sanofi
Apple
Google
insulin
Flag link:
Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label
Novo Nordisk seeks to include cardiovascular data in Tresiba insulin label
Drug Delivery Business News
Novo Nordisk
diabetes
FDA
Tresiba
insulin
Flag link:
Novo Basal Insulin Gets CHMP Nod to Update Label
Novo Basal Insulin Gets CHMP Nod to Update Label
Investopedia
Novo Nordisk
basal insulin
diabetes
CHMP
Tresiba
Flag link:
Sanofi sues Novo over 'misleading' Tresiba marketing materials
Sanofi sues Novo over 'misleading' Tresiba marketing materials
Fierce Pharma
Sanofi
Novo Nordisk
Tresiba
diabetes
Flag link:
Novo Nordisk: Why The Diabetes Giant Will Continue To Grow
Novo Nordisk: Why The Diabetes Giant Will Continue To Grow
Seeking Alpha
Novo Nordisk
diabetes
Tresiba
Saxenda
Victoza
Flag link:
Nordisk touts Tresiba insulin injection data
Nordisk touts Tresiba insulin injection data
Drug Delivery Business
Novo Nordisk
Tresiba
insulin
diabetes
insulin injection
Flag link:
Novo Shows Its Devotion To Tresiba's Cause
Novo Shows Its Devotion To Tresiba's Cause
Seeking Alpha
Novo Nordisk
diabetes
insulin
Tresiba
Flag link:
FDA staffers air concerns over Novo's Victoza-Tresiba combo
FDA staffers air concerns over Novo's Victoza-Tresiba combo
Fierce Pharma
FDA
Novo Nordisk
diabetes
Xultophy
Tresiba
Victoza
Flag link:
Novo makes inroads in Japan with long-acting insulin Tresiba
Novo makes inroads in Japan with long-acting insulin Tresiba
Fierce Pharma
Japan
Novo Nordisk
diabetes
insulin
Tresiba
Flag link:
Express Scripts unimpressed by insulin data on Novo's Tresiba
Express Scripts unimpressed by insulin data on Novo's Tresiba
BioPharma Dive
Express Scripts
insulin
Novo Nordisk
diabetes
Tresiba
Lantus
Flag link:
How Tresiba and Xultophy Will Drive Novo’s Performance
How Tresiba and Xultophy Will Drive Novo’s Performance
Yahoo/Market Realist
Novo Nordisk
Tresiba
Xultophy
earnings
Flag link:
Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial
Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial
BioPharma Dive
Novo Nordisk
insulin
diabetes
Tresiba
Lantus
Sanofi
Flag link:
Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share
Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share
Fierce Pharma
Novo Nordisk
Tresiba
diabetes
Flag link:

Pages